["{\n\"step_by_step_thinking\": \"The question is about the most commonly used drug for management of community-acquired pneumonia. The documents mention several types of pneumonia, including pneumococcal, staphylococcal, fungal, and gram-negative pneumonia. Community-acquired pneumonia can be caused by atypical pathogens such as Mycoplasma pneumoniae in young adults. Gram-negative bacilli are also common causes of community-acquired pneumonia. The documents do not mention specific antibiotics used for community-acquired pneumonia, but they do discuss antibiotic usage in general. The survey results mentioned that macrolides were rarely used as the treatment of choice for non-life-threatening pneumonia, while new beta-lactam antibiotics and aminoglycosides were commonly used for life-threatening pneumonia.\n\nConsidering these points, it is likely that the most commonly used drug for management of community-acquired pneumonia would be one that covers both pneumococci and atypical pathogens such as Mycoplasma pneumoniae. Azithromycin is a macrolide antibiotic that covers both pneumococci and atypical pathogens, making it a strong candidate for the most commonly used drug.\n\nIn addition, the survey results do not mention vancomycin, ceftriaxone, or streptomycin as being commonly used antibiotics for community-acquired pneumonia. Streptomycin is an aminoglycoside antibiotic that is not suitable for treating community-acquired pneumonia due to its low penetration into lung tissue.\n\nTherefore, based on the information provided, azithromycin seems to be the most likely answer.\",\n\"answer_choice\": C"]